Kronos Bio, Inc.
(NASDAQ GS: KRON)
Rigrodsky Law, P.A. is investigating Kronos Bio, Inc. (“Kronos”) regarding possible breaches of fiduciary duties and other violations of law related to Kronos’ agreement to be acquired by Concentra Biosciences, LLC. Under the terms of the agreement, Kronos shareholders will receive $0.57 per share in cash.